Total Funding
74
92
Total FundingFunding Round raised
Growth Score
5 pts
Heat Score
29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10808
28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.
- Benjamin Cappiello: Chief Business OfficerPast Role: Boston Biomedical Research Institute, Adult Stem Cell Research Intern
Stuart Gibb: VP of Sales & Marketing
About the Company
28bio is a biotechnology company focused on bridging the gap between human brain biology and drug development using proprietary neurotechnology. Its platform integrates tissue engineering, neural interfacing, and artificial intelligence to build engineered human brain organoids that mimic memory, learning, and other cognitive functions. The goal is
to provide more predictive and human-relevant models to improve the success rates of neurological drug discovery, reducing reliance on traditional animal models.
